Altor Completes Sale-Leaseback Transaction Generating Approximately $11 Million in Proceeds WESTPORT, Conn., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI”) today announced that its subsidiary, Altor Solutions (“Altor”), a leading designer and manufacturer of custom protective and cold-chain packaging solutions for the industrial and life sciences markets, completed a sale-leaseback transaction involving certain Altor-owned real estate assets, generating approximately $11 million in immediately-available cash proceeds. Altor will continue to operate at the fac...
Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares SAN DIEGO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that it has closed its previously announced upsized public offering of 25,875,000 shares of its common stock, including 3,375,000 shares sold pursuant to the underwriters’ full exercise ...
Moody's Ratings (Moody's) downgraded Compass Group Diversified Holdings LLC's (CODI) Corporate Family Rating (CFR) to B3 from B2, Probability of Default Rating to B3-PD from B2-PD, and the rating on the senior unsecured notes to Caa1 from B3. The rating outlook is negative. Previously, the ratings ...
Mission Produce Adopts Limited Duration Stockholder Rights Plan OXNARD, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (Nasdaq: AVO) (“Mission Produce” or the “Company”), a world leader in sourcing, producing, and distributing fresh Hass avocados, with additional offerings in mangos and blueberries, today announced that its Board of Directors has approved the adoption of a limited duration stockholder rights plan (the “Rights Plan”), effective January 21, 2026, with a one-year duration expiring on January 21, 2027. The Rights Plan was approved in response to the accumula...
Erasca Announces Pricing of Upsized Public Offering of Common Stock SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of an upsized public offering of 22,500,000 shares of its common stock. The shares of common stock are being sold to the public at a price of $10.00 per share. All of the shares of common stock to be sold in the public offering are to be sold by Erasca....
Erasca Announces Proposed Public Offering of $150 Million of Common Stock SAN DIEGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that it intends to offer and sell, subject to market and other conditions, $150.0 million of shares of its common stock in a proposed underwritten public offering. All of the shares of common stock to be sold in the proposed offering are being offered by Eras...
Mission Produce® Announces Agreement to Acquire Calavo Growers, Expanding North American Avocado Business and Diversifying Portfolio Across Fresh Produce Transaction seeks to enhance Mission’s position in the North American avocado category with expanded supply across Mexico and California Vertically integrated platform with sourcing security and produce diversification to better serve customers and grower partners worldwide Represents entry for Mission into the high-growth and attractive prepared food segment, complementing existing value-add avocado business Significant value creation ...
Compass Diversified Reports Third Quarter 2025 Financial Results WESTPORT, Conn., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market businesses, announced today its consolidated operating results for the three and nine months ended September 30, 2025 and filed its Quarterly Report on Form 10-Q for the period. “I’m pleased to report that with today’s filing we are now fully current with our SEC filings for 2025,” said Elias Sabo, Chief Executive Officer of Compass Diversified, “and we are in full compliance with ...
Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones Encouraging early clinical activity, including confirmed partial responses in multiple tumor types with different RAS mutations, coupled with promising safety and pharmacokinetics data, observed for ERAS-0015 during dose escalation Initial Phase 1 monotherapy data for ERAS-0015 (potential best-in-class pan-RAS molecular glue) planned for H1 2026 and for ERAS-4001 (potential first-in-class pan-KRAS inhibitor) planned for H2 2026 SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a...
Compass Diversified Announces Third Quarter and Year-to-Date 2025 Earnings and Conference Call Information WESTPORT, Conn., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market branded consumer and industrial businesses, announced today that it plans to report financial results for the third quarter ended September 30, 2025 on Wednesday, January 14, 2026 after market close. The Company has scheduled a conference call at 5:00 p.m. ET to review its third quarter and year-to-date financial results and business outlook...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.